Navigation Links
Clinical trial for diabetic macular edema enrolling patients
Date:3/26/2010

na Do of the Wilmer Eye Institute, researchers from 14 clinical centers throughout the U.S. enrolled 126 patients to compared the effectiveness of ranibizumab versus conventional treatment laser photocoagulation therapy. The study results showed a significantly greater improvement in vision in patients treated with ranibizumab than those receiving laser surgery or a combination of both.

Dr. Nguyen, Dr. Campochiaro, Dr. Do, and 14 other clinician scientists from clinical centers in California, Florida, Hawaii, Illinois, Kansas, Maryland, Pennsylvania, South Dakota, and Texas designed the READ-3 Study.

Ranibizumab was approved by the U.S. Food and Drug Administration for the treatment of patients with a type of age-related macular degeneration in June 2006. In addition to the READ studies, Genentech is conducting two parallel, phase 3 trials studying the safety and efficacy of different doses of ranibizumab to treat diabetic macular edema.


'/>"/>

Contact: Joana Casas
mcasas@jdrf.org
212-479-7560
Juvenile Diabetes Research Foundation International
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Singapore program to provide clinical insight; showcase for regional research
2. AADR awards 2010 Neal W. Chilton Fellowship in Clinical Research to Dolphus Dawson, III
3. Cell-enriched fat grafts improve long term graft retention in preclinical study
4. GenWay Clinical Laboratory receives accreditation from College of American Pathologists
5. UAB bone center director wins distinguished service award from clinical pathology society
6. TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services
7. Magnetic nanotags spot cancer in mice earlier than methods now in clinical use
8. RadMD reaches 150th clinical trial
9. New cancer drug test promises safer and more effective clinical trials
10. IRSF announces funding of first clinical trial with disease-modifying therapy for Rett syndrome
11. General tumor marker test now offered by GenWay clinical laboratory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... antioxidants and can reduce free radical damage. ... oxidative stress? Jianbo Zhao and co-workers from ... University, China discovered that green tea polyphenol ... apoptosis, indicating green tea polyphenols play a ... oxidative stress. The relevant study has been ...
(Date:8/21/2014)... smog-producing toxins in past decade, GTA still violates ... that while the Greater Toronto Area (GTA) has ... to smog, the city continues to violate the ... can cause or aggravate health problems such as ... a set of complex photochemical reactions involving volatile ...
(Date:8/21/2014)... dandruff, eczema and other itchy, flaky maladies in humans ... Hawaiian coral reefs and the extreme environments of arctic ... the scientific journal PLOS Pathogens considers the ... genus Malassezia in light of new insights ... world. , University of Hawai,i at Mānoa scientist Anthony ...
Breaking Biology News(10 mins):Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canada's standards for ozone air pollution 2From dandruff to deep sea vents, an ecologically hyper-diverse fungus 2
... and Amsterdam, The Netherlands, January 14, 2008 A ... E genotypes has been developed by researchers from the ... Southern Medical University, Guangzhou, China. This assay combines PCR ... genotyping of the human population, which in turn will ...
... have a skull that functioned like a fish-eating crocodile, despite ... claws, perhaps used as grappling hooks to lift fish from ... Bristol, UK, used computer modelling techniques more commonly used ... to show that while Baryonyx was eating, its skull ...
... 20,000 people found seven new genes that influence blood ... confirmed 11 other genes previously thought to influence ... from the University of Michigan School of Public Health ... influence lipid levels, and secondly, to see if those ...
Cached Biology News:New method developed to identify genetic determinants of Alzheimer's disease 2Unusual fish-eating dinosaur had crocodile-like skull 2Study locates cholesterol genes; finds surprises about good, bad cholesterol 2
(Date:8/21/2014)... New Rochelle, N.Y. (PRWEB) August 21, 2014 ... it is the first private college in the Mid-Hudson ... The College will now begin accepting applications from qualified ... , “We are very pleased to have been ... to support Governor Cuomo’s transformative initiative to stimulate economic ...
(Date:8/21/2014)... NEW YORK , Aug. 21, 2014 /PRNewswire/ ... OTCM) congratulates Immune Pharmaceuticals Inc., a biotechnology company, ... Capital Market.  Immune previously traded on OTCQX®, the ... operated by OTC Markets Group. Logo - ... Immune Pharmaceuticals on the successful execution of its ...
(Date:8/21/2014)... 21, 2014 Pursuit Solutions ( ... technology and services for Life Sciences sales and ... Use of New Commercial Sales Models” by Peter ... , The article examines some innovative models used ... being tested in the pharmaceutical market. Robinson grades ...
(Date:8/21/2014)... SoundConnect , a unified communication ... of the nation’s Fastest Growing Private Companies by ... consecutive year. Inc. magazine today ranked SoundConnect NO. ... exclusive ranking of the nation's fastest-growing private companies. ... the most important segment of the economy—America’s independent ...
Breaking Biology Technology:The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 2The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 3OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 3
... Inc.,(Nasdaq: VRML ), a molecular diagnostics company, ... its board of directors. Mr. Hamilton is,the former ... Inc., a,specialty pharmaceutical company., "John brings more ... strategic and audit matters to Vermillion. His solid ...
... Interim Leadership Responsibility, PRINCETON, N.J., April 10 ... the discovery and development of novel,small molecule therapeutics, ... as President and Chief Executive Officer and a ... pursue other interests. His resignation was,effective April 9, ...
... SEATTLE, April 10 Amnis Corporation announced today ... analysis software.,IDEAS version 3.0 incorporates greatly expanded analytical ... IDEAS 3.0 provides the user with dozens ... to strengthen morphological,data analysis. The new software also ...
Cached Biology Technology:Vermillion Announces Appointment of John Hamilton to Board of Directors 2Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc. 2Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc. 3Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc. 4Amnis Announces Release of Powerful New Image Data Analysis Software 2
geminin, DNA replication inhibitor...
Normal human serum, single donor...
One-step, microplate or cuvet, colorimetric, linear detection range 0.1 mg/dL to 100 mg/dL. Procedure: 20 min....
... Certified USDA Research Registered OLAW Assured AAALAC ... AALAS Certified Technicians Documentation ... Upon Request Focus CRP is ... your custom immunology service needs. We ...
Biology Products: